We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Differences Between Two Cancer-promoting Enzymes Discovered

News   Mar 28, 2019 | Original story from the University of Würzburg

 
Differences Between Two Cancer-promoting Enzymes Discovered

Structures of the catalytic domains of USP28 and USP25: USP28 is a constitutively active dimer and can bind and process ubiquitin (orange) at any time. In contrast, USP25 is a tetramer composed of two inter-linked USP28-like dimers (blue / gray and yellow / green) and this arrangement prevents binding of the substrate rendering the enzyme inactive. Credit: Rudolf Virchow Center of experimental biomedicine / University of Wuerzburg

 
 
 

RELATED ARTICLES

The Power of Collaboration: Tackling Pharmaceutical Challenges

News

In this article, we explore how pharmaceutical companies have started to embrace a more collaborative way of working as part of a movement to help overcome some of the challenges the industry is facing.

READ MORE

Worms Reveal Critical Step in Insulin Synthesis

News

The identification of a protein important for insulin synthesis may hold clues for understanding the pathogenesis of diabetes.

READ MORE

A New Treatment For Elephantiasis?

News

Using RNA sequencing techniques, researchers have discovered that an experimental cancer drug could be used to treat a disabling parasitic disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE